Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Notice of Pre-Application Webinar for RFA-AG-19-010: "Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed)"
National Institute on Aging - Notice of Correction to the Funding Opportunity Description for PAR-18-899 "Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)"
National Institute of Arthritis and Musculoskeletal and Skin Diseases - Notice of Correction to the Funding Opportunity Description for PAR-18-900 "Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)"
National Institute of Arthritis and Musculoskeletal and Skin Diseases - Notice of Clarification to Additional Information on Eligibility and Number of Applications in Funding Opportunity Announcement (FOA) PAR-18-880, "NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)".
National Cancer Institute - Notice of Change to Application Types Allowed for PAR-18-919 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)"
National Cancer Institute - Notice of a Pre-Application Webinar for RFA-CA-19-016 "Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54)"
National Cancer Institute - Notice to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-18-906 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
National Institute on Drug Abuse
National Eye Institute
National Institute of Biomedical Imaging and Bioengineering
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Request for Information: Optimizing the Design and Implementation of Emergency Medical Care Research Conducted Under Exception from Informed Consent Requirements for Emergency Research (EFIC) Requirements and Guidelines
National Heart, Lung, and Blood Institute
National Institute of Neurological Disorders and Stroke - Notice of Clarification: Research Strategy page limit for PA-18-794, AHRQ Small Research Grant Program (R03)
Agency for Healthcare Research and Quality - Special Reminder: AHRQ Natural Disaster Policy - Hurricane Florence
Agency for Healthcare Research and Quality
Requests for Applications
- Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA and CDC Funding (R61/R33 - Clinical Trials Optional)
National Institute on Drug Abuse
Office of Behavioral and Social Science Research
- Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R43/R44 - Clinical Trial Optional)
- Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R41/R42 - Clinical Trial Optional)
National Institute on Drug Abuse
- NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)
- BRAIN Initiative Cell Census Network (BICCN) Specialized Collaboratory on Human and Non-Human Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R01 Clinical Trial Optional)
- Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R21 Clinical Trial Optional)
National Institute of Mental Health
- Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
- Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Nursing Research
National Library of Medicine
- Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Science Research
Office of Research on Women's Health
Program Announcements
- Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp)
National Institute of Allergy and Infectious Diseases
- Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical Trial Optional)
- Innovative Technologies for HIV Behavioral and Social Science Research (R43/R44 Clinical Trial Optional)
National Institute of Mental Health
- Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)
Office of Disease Prevention
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
- Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required)
National Institute of Diabetes and Digestive and Kidney Diseases
- Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required)
National Institute of Diabetes and Digestive and Kidney Diseases
- High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
- Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl - Clinical Trial Not Allowed)
National Cancer Institute
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Paul Below at paul-below@uiowa.edu, or Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu.